Cybin Inc. to Present at Atai Life Sciences AGPS Showcase
Ticker: HELP · Form: 6-K · Filed: May 14, 2025 · CIK: 1833141
Sentiment: neutral
Topics: event-participation, news-release, biotech
Related Tickers: CYBN
TL;DR
Cybin Inc. is presenting at Atai Life Sciences AGPS Showcase on May 14, 2025.
AI Summary
Cybin Inc. filed a Form 6-K on May 14, 2025, to report its participation in the Atai Life Sciences AGPS Showcase. The filing includes a news release dated May 14, 2025, announcing this participation. Doug Drysdale, CEO of Cybin Inc., signed the report.
Why It Matters
This filing indicates Cybin Inc.'s engagement with a significant player in the life sciences sector, potentially highlighting its progress and attracting investor attention.
Risk Assessment
Risk Level: low — This is a routine filing announcing participation in an industry event, with no immediate financial or operational risks disclosed.
Key Players & Entities
- Cybin Inc. (company) — Registrant
- Atai Life Sciences (company) — Event Host
- Doug Drysdale (person) — CEO and Signatory
- May 14, 2025 (date) — Filing and News Release Date
FAQ
What is the purpose of Cybin Inc.'s Form 6-K filing on May 14, 2025?
The Form 6-K filing on May 14, 2025, is to report Cybin Inc.'s participation in the Atai Life Sciences AGPS Showcase and includes a related news release.
Who signed the Form 6-K filing on behalf of Cybin Inc.?
Doug Drysdale, Chief Executive Officer of Cybin Inc., signed the Form 6-K filing.
What is the exact date of the news release attached to this filing?
The news release attached to this filing is dated May 14, 2025.
What is Cybin Inc.'s principal executive office address?
Cybin Inc.'s principal executive office is located at 100 King Street West, Suite 5600, Toronto, Ontario, M5X 1C9.
Which SEC Act is this Form 6-K filed under?
This Form 6-K is filed under the Securities Exchange Act of 1934.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 14, 2025 by Doug Drysdale regarding CYBIN INC. (HELP).